The incidence of chronic obstructive pulmonary disease (COPD) and cystic fibrosis is rising across the region. According to the World Health Organization (WHO), COPD exacerbations are critical events in the history of COPD. Also, the COPD-related disability and mortality propel the demand for Oscillating Positive Expiratory Pressure (OPEP) devices. Asthma is becoming common among people of all ages, genders, and races. As per the 2018 Global Asthma Report published in Auckland, New Zealand, asthma is the 16th largest cause of disability and the 28th greatest source of disease burden, as assessed by disability-adjusted life years. Asthma is common in high-income nations, whereas the majority of asthma-related deaths occur in low- and middle-income countries. Therefore, the rising prevalence of COPD and asthma propels the demand for mucous clearing devices, such as OPEP devices, which bolsters the growth of the oscillating positive expiratory pressure (OPEP) devices market.
With new features and advanced technologies, vendors can attract new customers and expand their footprints in emerging markets.This factor is likely to drive the Europe oscillating positive expiratory pressure (OPEP) devices market at a notable CAGR during the forecast period.
Europe Oscillating Positive Expiratory Pressure (OPEP) Devices Market Segmentation
The Europe oscillating positive expiratory pressure (OPEP) devices market is segmented on the basis of product, indication, distribution channel, and country. Based on product, the market is segmented into mouthpiece PEP devices, face mask PEP devices, and bottle PEP devices. In 2021, the mouthpiece PEP devices segment accounted for the largest market share; and it is likely to register the highest CAGR during the forecast period. Based on indication, the market is categorized into chronic obstructive pulmonary disease (COPD), asthma, bronchitis, bronchiectasis, cystic fibrosis, and others. In 2021, the chronic obstructive pulmonary disease (COPD) segment accounted for the largest share of the market; however, the asthma segment is likely to register the highest CAGR during the forecast period. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. In 2021, the hospital pharmacies segment held the largest market share; however, the retail pharmacies segment is expected to register the highest CAGR in the market during the forecast period. Further, based on country, the market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. In 2021, Germany held the largest market share, and France is expected to register the highest CAGR during the forecast period.
Allergan Plc.; PARI GmbH; Smiths Medical; AirPhysio; Mercury Medical; CEGLA Medizintechnik GmbH & Co. KG; and Medica Holdings, LLC are among some of the leading companies operating in the Europe oscillating positive expiratory pressure (OPEP) devices market.